Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Debt / NOTE 0.599% 8/0
-
Number of holders
-
0
-
Total 13F principal, excl. options
-
0
-
Principal change
-
-504,939,000
-
Total reported value, excl. options
-
$0
-
Value change
-
-$501,725,739
-
Number of sells
-
-47
Significant Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q3 2024
47 filings reported holding 09061GAH4 - BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 as of Q3 2024.
BIOMARIN PHARMACEUTICAL INC - NOTE 0.599% 8/0 has 0 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $0 of principal
.
Largest 10 bondholders include Sonora Investment Management Group, LLC ($0 of principal), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($0 of principal), Calamos Wealth Management LLC ($0 of principal), NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO ($0 of principal), AVIVA PLC ($0 of principal), UBS Group AG ($0 of principal), STATE STREET CORP ($0 of principal), MACQUARIE GROUP LTD ($0 of principal), BANK OF AMERICA CORP /DE/ ($0 of principal), and MILLENNIUM MANAGEMENT LLC ($0 of principal).
This table shows the top 0 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.